Linda McAllister has joined Toronto-based molecular diagnostics firm Xagenic as chief medical officer.
McAllister previously has worked on the development and launch of molecular technologies at Roche Diagnostics, Celera Diagnostics, and Affymetrix. She most recently was CMO at the prenatal genetic testing company Cellscape, and she was CMO and VP of R&D at Pharmajet. She also was an adjunct clinical professor in the University of California, San Francisco department of medicine from 1992 to 2005, and a research fellow at Stanford University.
Mostafa Ronaghi has joined BaseHealth's board of directors.
Ronaghi currently serves as Illumina's chief technology officer and senior vice president. Before joining Illumina, he founded several life sciences companies including ParAllele BioScience, which was acquired by Affymetrix, as well as Avantome and NextBio, both of which were acquired by Illumina. He also previously spent nine years as a principal investigator at the Stanford Genome Technology Center.